We are live on
!
Find out more
BAM
Broadcrest Asset Management Portfolio holdings
AUM
$44.1M
1-Year Est. Return
4.51%
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.4M
AUM Growth
-$36.2M
(-33%)
Cap. Flow
-$36.7M
Cap. Flow
% of AUM
-49.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
4
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$15.7M |
| 2 |
Transcat
TRNS
|
+$10.6M |
| 3 |
Nomad Foods
NOMD
|
+$6.78M |
| 4 |
Tyler Technologies
TYL
|
+$2.14M |
| 5 |
HEICO Corp Class A
HEI.A
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 69.71% |
| 2 | Technology | 11.42% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Healthcare | 7.56% |
| 5 | Consumer Staples | 0% |
Similar funds
MAM
WCPI
NLVP
WAMC
CIEP
IPI
CC
VSAM
Broadcrest Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Broadcrest Asset Management held 6 positions worth $74.4M, down 33% from $111M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadcrest Asset Management withdrew a net $36.7M in Q1 2024, closing 1 position and reducing 4 holdings. Its most notable exit was Nomad Foods, an estimated $6.78M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 70% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.
- Broadcrest Asset Management's biggest Q1 2024 reduction was Bio-Techne, cutting an estimated $15.7M.
- Broadcrest Asset Management fully exited Nomad Foods in Q1 2024, selling an estimated $6.78M.
- Broadcrest Asset Management's ten largest holdings make up 100% of its $74.4M portfolio in Q1 2024.
- Broadcrest Asset Management opened 0 new positions and closed 1 in Q1 2024.
- Broadcrest Asset Management's portfolio value fell 33% quarter-over-quarter to $74.4M.
Based on Broadcrest Asset Management's 13F filing for Q1 2024, filed 13 May 2024.